1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. France >
  5. Avax Technologies Acquires Genopoietic S.A.

M&A Deal Summary

Avax Technologies Acquires Genopoietic S.A.

On August 24, 2000, Avax Technologies acquired life science company Genopoietic S.A.

Acquisition Highlights
  • This is Avax Technologies’ 1st transaction in the Life Science sector.
  • This is Avax Technologies’ 1st transaction in France.

M&A Deal Summary
Date 2000-08-24
Target Genopoietic S.A.
Sector Life Science
Buyer(s) Avax Technologies
Deal Type Add-on Acquisition

Target

Genopoietic S.A.

Miribel, France
Genopoietic S.A. is a biotechnology company develops autologous chondrocytes for cartilage repair and gene therapy to treat cancer, as well as to treat graft-versus-host disease.

Search 214,557 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Avax Technologies

Philadelphia, Pennsylvania, United States
Category Company
Founded 1990
Sector Life Science
Employees9
Revenue 1M USD (2007)
DESCRIPTION

Avax Technologies is a biotechnology company. The company is engaged in the research, clinical and commercial development of biological products and cancer therapeutics. AVAX Technologies was incorporated in 1990 and is headquartered in Philadelphia, Pennsylvania.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: France M&A 1 of 1
Year: 2000 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal